Drug intelligence / Profile preview

anti-Eimeria tenella IgG2a

Development stage
Unknown
Lead developer
Pfizer
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intraperitoneal, Subcutaneous
01

Overview

anti-Eimeria tenella IgG2a is a monoclonal antibody of the IgG2a isotype specifically directed against antigens of *Eimeria tenella*, a protozoan parasite that causes coccidiosis in poultry. In the context of immunological research and preclinical drug development, this antibody is primarily utilized as an **isotype control**. Because its target is a non-mammalian pathogen, it does not bind to mouse or human proteins, making it an ideal negative control for evaluating the specific effects of other IgG2a-based therapeutic candidates (such as anti-IL25 antibodies). It allows researchers to account for non-specific binding or Fc-receptor-mediated biological activities in various experimental systems, including the Aldara-induced psoriasiform skin inflammation model and the IL25-mediated air pouch recruitment model.

Other names
anti-E. tenella isotype control antibodyanti-E. tenella IgG2aanti-Eimeria tenella monoclonal antibody

Beyond the preview

Go deeper on anti-Eimeria tenella IgG2a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-Eimeria tenella IgG2a.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call